secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001437749-23-015120
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica Therapeutics shareholders approve articles amendments and elect directors at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to articles enhancing director nomination procedures referencing universal proxy rules with 4,520,227 votes for.
- Shareholders approved amendment granting board sole authority to fix number of directors with 3,403,969 votes for.
- Six director nominees elected: Richard Pilnik, Michael Giuffre, Tanya Lewis, James Parsons, Rick Pauls, Charles Semba.
- Appointment of Baker Tilly US, LLP as independent auditor approved with 13,051,215 votes for.
- Meeting held May 17, 2023; quorum of 50.4% of outstanding shares present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774923015120/0001437749-23-015120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774923015120/dmtp20230518_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-015120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer